Teva Pharmaceutical Industries Ltd
NYSE · Healthcare · Pharmaceutical Preparations · Tel Aviv
TEVA chart
What traders are saying about $TEVA
Latest postsTeva Pharmaceutical Industries Ltd news
- Teva Pharmaceutical Industries Ltd. $TEVA Position Trimmed by Private Management Group Inc.
MarketBeat ·
- Teva stock: Guidance lift meets Samsung Bioepis valuation test
ad-hoc-news.de ·
- Teva Pharmaceutical Industries (TEVA) Following Guidance Lift And Samsung Bioepis Deal Is It Fully Valued
Simply Wall St ·
- A European commercial executive proposes selling 25,000 Teva (TEVA) shares.
Stock Titan ·
- Teva committed to working with Irish healthcare professionals despite boycotts
The Jerusalem Post ·
- Teva stock: Innovative brands lift 2026 revenue outlook
ad-hoc-news.de ·
- FDA Decision Watch: Summit’s Lung Cancer Drug, Cytokinetics’ Heart Therapy And Teva’s Igalmi In Spotlight This Week
stocktwits.com ·
- Teva stock outlook strengthens as innovative brands expand
ad-hoc-news.de ·
- Teva Pharmaceutical Industries Ltd. $TEVA Stock Position Reduced by Carnegie Lake Advisors LLC
MarketBeat ·
- Teva Pharmaceutical Industries Ltd (TEVA.HA) balance sheet – Yahoo Finance
Yahoo Finance Singapore ·
- Teva Pharmaceutical Industries Ltd (TEVA.HA) stock price, news, quote and history
Yahoo Finance Singapore ·
- Teva Pharmaceutical Industries Limited (TEVA.TA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
Teva Pharmaceutical Industries Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $17.26B | $16.54B | $15.85B | $14.93B |
| Net income | $1.41B | -$1.64B | -$559.0M | -$2.45B |
| Diluted EPS | $1.21 | $-1.45 | $-0.50 | $-2.20 |
| Total assets (year end) | $40.75B | $39.33B | $43.48B | $44.01B |
| Cash and equivalents (year end) | $3.56B | $3.30B | $3.23B | $2.80B |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Teva Pharmaceutical Industries Ltd
- Ticker
- TEVA (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Tel Aviv
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 818686
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Frequently asked questions
What exchange is Teva Pharmaceutical Industries Ltd listed on?
Teva Pharmaceutical Industries Ltd trades on the NYSE under the ticker symbol TEVA.
What industry is Teva Pharmaceutical Industries Ltd in?
Teva Pharmaceutical Industries Ltd is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Teva Pharmaceutical Industries Ltd headquartered?
Teva Pharmaceutical Industries Ltd's business address on file with the SEC is in Tel Aviv.
When does Teva Pharmaceutical Industries Ltd's fiscal year end?
Teva Pharmaceutical Industries Ltd's fiscal year ends on December 31.
How much revenue did Teva Pharmaceutical Industries Ltd report?
Teva Pharmaceutical Industries Ltd reported $17.26B in revenue for calendar year 2025, according to its SEC filings.